Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the safety and efficacy of adalimumab compared to
placebo in subjects with rheumatoid arthritis on methotrexate therapy.